Stockscreener 앱 받기
18.28
5.30%
0.92
시간 외 거래:
18.48
0.20
+1.09%
전일 마감가:
$17.36
열려 있는:
$17.65
하루 거래량:
29,856
Relative Volume:
0.45
시가총액:
$41.01M
수익:
$215.91M
순이익/손실:
$-4.26M
주가수익비율:
-114.25
EPS:
-0.16
순현금흐름:
$-8.27M
1주 성능:
-4.69%
1개월 성능:
-30.76%
6개월 성능:
+192.48%
1년 성능:
+4,265%
1일 변동 폭
$17.41
$18.57
1주일 범위
$17.00
$19.84
52주 변동 폭
$0.3133
$35.50
Regis Corp. Stock (RGS) Company Profile
명칭
Regis Corp.
전화
952-947-7777
주소
7201 Metro Boulevard, Edina, MN
RGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| RGS | 18.28 | 41.01M | 215.91M | -4.26M | -8.27M | -0.16 |
| ROL | 50.05 | 24.24B | 3.31B | 469.51M | 537.75M | 0.83 |
| SCI | 86.10 | 12.45B | 4.15B | 505.69M | 587.50M | 3.18 |
| HRB | 60.35 | 8.42B | 3.61B | 595.32M | 657.18M | 3.57 |
| BFAM | 108.00 | 6.28B | 2.63B | 116.59M | 216.16M | 1.49 |
| FTDR | 54.29 | 4.12B | 1.83B | 234.00M | 235.00M | 2.11 |
Regis Corp. Stock (RGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-02-01 | 업그레이드 | Loop Capital | Hold → Buy |
| 2021-01-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-10-22 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2019-04-05 | 개시 | Loop Capital | Buy |
| 2017-12-21 | 개시 | KeyBanc Capital Mkts | Sector Weight |
| 2017-09-13 | 개시 | Jefferies | Buy |
| 2016-05-19 | 다운그레이드 | Piper Jaffray | Neutral → Underweight |
| 2015-11-19 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2015-10-30 | 업그레이드 | Northcoast | Sell → Neutral |
| 2015-08-31 | 다운그레이드 | Northcoast | Buy → Neutral |
| 2011-03-01 | 개시 | Oppenheimer | Outperform |
| 2010-12-21 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2010-10-29 | 재확인 | Feltl & Co. | Hold |
| 2010-10-29 | 재확인 | Wedbush | Neutral |
| 2010-07-09 | 다운그레이드 | Feltl & Co. | Buy → Hold |
| 2010-01-12 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2009-12-04 | 개시 | Wedbush Morgan | Neutral |
| 2009-08-21 | 재확인 | Credit Suisse | Outperform |
| 2009-08-21 | 업그레이드 | Feltl & Co. | Hold → Buy |
| 2009-08-13 | 개시 | Feltl & Co. | Hold |
| 2009-07-31 | 개시 | Credit Suisse | Outperform |
모두보기
Regis Corp. 주식(RGS)의 최신 뉴스
Regis Corporation (NYSE:RGS) Q1 2025 Earnings Call Transcript - Insider Monkey
Regis Corp (RGS) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives By GuruFocus - Investing.com Canada
Regis: Fiscal Q1 Earnings Snapshot - Houston Chronicle
Regis Corporation Reports Continued Profitability for the First Fiscal Quarter 2025 - Yahoo Finance
Regis Corp Reports Q1 2025 Earnings: Adjusted EPS at $0.93, Reve - GuruFocus.com
Regis to Issue First Quarter Fiscal 2025 Results on November 6, 2024 - StockTitan
Supercuts® Debuts Nationwide Loyalty Program with Guests Able to Earn Free Haircuts and More - Quantisnow
Lapses in autopsy report: RG Kar doctor at CBI office for interrogation - Lokmat Times
RG Kar case: CBI finds more procedural lapses in autopsy report - Lokmat Times
Keros Therapeutics Inc [KROS] Insider GORDON CARL L sells 250,000 Shares for $250,000 - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Regeneron slump continues as analysts turn more cautious - MSN
Keros Therapeutics Inc (KROS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
GRI’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Closing Strong: Mereo Biopharma Group Plc ADR (MREO) Ends at 4.09, Down -3.76 from Last Close - The Dwinnex
GEELY AUTO Partners with Tasco to Set Up Auto Assembly Plant in Vietnam w/ Total Investment Amt ~US$168M - AASTOCKS.com
Cong asks Guv to intervene in “illegally IPB permitted” mega projects in Reis Magos - Herald Goa
Keros Therapeutics (NASDAQ:KROS) Shares Gap Up to $55.80 - MarketBeat
How the (KROS) price action is used to our Advantage - Stock Traders Daily
How does Keros Therapeutics Inc (KROS) change from a tortoise to a hare? - SETE News
Keros Therapeutics (NASDAQ:KROS) Receives New Coverage from Analysts at Guggenheim - MarketBeat
Guggenheim starts Keros Therapeutics with 'buy' on lung disorder drug potential - XM
Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects - Investing.com Australia
Regis drops $103.5m on aged care villages - realestatesource.com.au
Public Employees Retirement Association of Colorado Sells 674 Shares of Targa Resources Corp. (NYSE:TRGP) - Defense World
Latest News LIVE Updates: RG Kar junior doctors withdraw 42-day `cease work` - mid-day.com
Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $3.95 - Defense World
RG Kar scam: CBI gets clues of Sandip Ghosh illegally awarding contracts to biz entity - Punjab News Express
Regis Healthcare (ASX:REG) share price jumps on acquisition, aged care reforms - Rask Media
Australia's Regis Healthcare hits over 8-yr high as co plans to acquire residential homes - XM
Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition - MSN
Edgestream Partners L.P. Makes New Investment in Herc Holdings Inc. (NYSE:HRI) - Defense World
Mereo BioPharma Group plc (NASDAQ:MREO) Insider Sells $23,297.64 in Stock - Defense World
Odisha: Government introduces new safety policy for medical professionals Post RG Kar rape incident - Organiser
R G Kar case: ED summons TMC MLA Sudipto Roy for questioning - NewsDrum
ED seizes documents from TMC MLA’s home in RG Kar Hospital bungling case - Medical Buyer
RG Kar case: CPI(M) youth leader Minakshi Mukherjee appears before CBI - The Economic Times
Mereo BioPharmaLazarus-Like Recovery Impresses, But Lack Of Clarity On Potential Approval Timelines - Seeking Alpha
After RG Kar Episode In Kolkata, Odisha Govt Issues Guidelines For Doctors’ Safety - OdishaBytes
Mereo Biopharma Group Plc ADR (MREO) stock: A year of ups and downs - US Post News
Mereo Biopharma Group Plc ADR (MREO) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Mereo BioPharma Group plc (MREO): A Bull Case Theory - Insider Monkey
'Next decade is likely to be a golden era' for ASX shares in this sector - The Motley Fool Australia
BMO holds stock target, outperform rating on Regeneron shares - Investing.com India
Mereo BioPharma Group plc (NASDAQ:MREO) CEO Denise Scots-Knight Sells 28,611 Shares - Defense World
Mereo BioPharma Group plc (NASDAQ:MREO) CFO Christine Ann Fox Sells 9,128 Shares of Stock - Defense World
Mereo BioPharma CFO sells over $121k in company stock - Investing.com
Mereo BioPharma's chief scientific officer sells shares worth over $69,000 - Investing.com India
Mereo BioPharma CFO sells over $120k in company stock - Investing.com India
Mereo BioPharma's general counsel sells over $133k in company stock - Investing.com UK
Views of Wall Street’s Leading Experts on Mereo Biopharma Group Plc ADR - SETE News
Regis Corp. (RGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.75%
2.25%
자본화:
|
볼륨(24시간):